BPG is committed to discovery and dissemination of knowledge
Articles in Press
5/29/2025 7:04:39 AM | Browse: 26 | Download: 0
Category |
Immunology |
Manuscript Type |
Minireviews |
Article Title |
Adoptive cell therapy in colorectal cancer: Focus on chimeric antigen receptor T cells
|
Manuscript Source |
Invited Manuscript |
All Author List |
Meng-Yan Chen, Chen Wang, Yu-Gang Wang and Min Shi |
Funding Agency and Grant Number |
Funding Agency |
Grant Number |
Natural Science Foundation of the Science and Technology Commission of Shanghai Municipality, China |
No. 23ZR1458300 |
Key Discipline Project of Shanghai Municipal Health System, China |
No. 2024ZDXK0004 |
Doctoral Innovation Talent Base Project for Diagnosis and Treatment of Chronic Liver Diseases, China |
No. RCJD2021B02 |
Pujiang Project of Shanghai Magnolia Talent Plan, China |
No. 24PJD098 |
|
Corresponding Author |
Min Shi, Chief Physician, MD, Department of Gastroenterology, Tongren Hospital, Shanghai Jiao Tong University School of Medicine, No. 1111 Xianxia Road, Changning District, Shanghai 200336, China. sm1790@shtrhospital.com |
Key Words |
Colorectal cancer; Adoptive cell therapy; Immunotherapy; Chimeric antigen receptor T cells; Tumor-infiltrating lymphocytes; T-cell receptor-engineered T cells |
Core Tip |
This review discusses adoptive cell therapy approaches for colorectal cancer (CRC), emphasizing chimeric antigen receptor (CAR) T cell therapy. Despite its success in hematological malignancies, CAR-T therapy faces challenges in solid tumors like CRC, including antigen heterogeneity, tumor microenvironment immunosuppression, and on-target off-tumor toxicity. The review explores combinatorial strategies, such as immune checkpoint inhibitors and clustered regularly interspaced short palindromic repeats/Cas9 gene editing, to overcome these challenges and enhance CAR-T cell specificity, resistance to immunosuppressive signals, and in vivo functionality. |
Citation |
Chen MY, Wang C, Wang YG, Shi M. Adoptive cell therapy in colorectal cancer: Focus on chimeric antigen receptor T cells. World J Gastrointest Oncol 2025; In press |
 |
Received |
|
2025-03-06 09:04 |
 |
Peer-Review Started |
|
2025-03-06 09:04 |
 |
To Make the First Decision |
|
|
 |
Return for Revision |
|
2025-03-26 11:19 |
 |
Revised |
|
2025-04-07 10:27 |
 |
Second Decision |
|
2025-05-29 02:49 |
 |
Accepted by Journal Editor-in-Chief |
|
|
 |
Accepted by Executive Editor-in-Chief |
|
2025-05-29 07:04 |
 |
Articles in Press |
|
2025-05-29 07:04 |
 |
Publication Fee Transferred |
|
|
 |
Edit the Manuscript by Language Editor |
|
|
 |
Typeset the Manuscript |
|
|
ISSN |
1948-5204 (online) |
Open Access |
This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: https://creativecommons.org/Licenses/by-nc/4.0/ |
Copyright |
© The Author(s) 2024. Published by Baishideng Publishing Group Inc. All rights reserved. |
Permissions |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
|
Publisher |
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA |
Website |
http://www.wjgnet.com |
© 2004-2025 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
California Corporate Number: 3537345